Showing results (571-580 of 673) with videos related to
Sort By:
Pageof 68
Intensive Care Medicine|March 18, 2024
The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infectionsNiccolò Buetti, Alexis Tabah, Nour Setti, et al.Open Forum Infectious Diseases|November 19, 2021
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case StudyChiara Sepulcri, Chiara Dentone, Malgorzata Mikulska, et al.Journal of Clinical Microbiology|March 24, 2022
Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis StudyDaniele Roberto Giacobbe, Juergen Prattes, Joost Wauters, et al.Pulmonary Pharmacology & Therapeutics|July 2, 2017
Individualizing duration of antibiotic therapy in community-acquired pneumoniaStefano Aliberti, Julio Ramirez, Fabio Giuliani, et al.Journal of Travel Medicine|August 14, 2020
Travel-related hepatitis E: a two-decade GeoSentinel analysisLaura Ambra P Nicolini, Rhett J Stoney, Andrea Della Vecchia, et al.Journal of Chemotherapy (Florence, Italy)|August 20, 2024
COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospitalSilvia Dettori, Giorgia Brucci, Federica Portunato, et al.Journal of Chemotherapy (Florence, Italy)|December 14, 2023
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surgeClaudia Bartalucci, Alessandro Limongelli, Laura Ambra Nicolini, et al.The Journal of Antimicrobial Chemotherapy|February 17, 2024
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoringMalgorzata Mikulska, Monica Melchio, Alessio Signori, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2025
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter StudyAntonio Vena, Giusy Tiseo, Marco Falcone, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 19, 2021
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Elena Carrara, Pilar Retamar, et al.Pageof 68